For patients living with persistent pain after spinal surgery—a condition often called Failed Back Surgery Syndrome (FBSS)—the path forward is rarely straightforward. Revision surgery may seem like the logical next step, but many candidates find meaningful relief through minimally invasive biologic disc repair instead. Outcomes vary significantly by individual, and a thorough evaluation is essential before any decision.

Understanding Failed Back Surgery Syndrome

Failed Back Surgery Syndrome is not a single diagnosis. It is an umbrella term describing persistent or new pain that continues after spinal surgery. Patients may experience a range of symptoms, including localized low back pain, radiating nerve pain (sciatica), numbness, weakness, or muscle spasms. The emotional burden—including anxiety and depression related to prolonged suffering—can be equally significant.

FBSS can arise from many causes: an incomplete initial diagnosis, scar tissue formation, hardware complications, inadequate nerve decompression, or the development of adjacent segment disease above or below a previous fusion. Because the underlying source of pain varies from person to person, treatment decisions must be highly individualized.

Expert Take

Our clinical team emphasizes that FBSS is rarely a single, uniform problem. Identifying the precise pain generator—whether it is residual disc pathology, scar tissue, or adjacent segment stress—is foundational to choosing the right next step. Patients are evaluated individually before any treatment pathway is recommended.

Revision Surgery: What It Involves and Why It Carries Elevated Risk

When initial surgery fails to resolve pain, revision surgery is often presented as the next logical option. However, it is a decision that warrants careful deliberation. Revision procedures are generally more complex than the original surgery because the surgeon must navigate through scar tissue, altered anatomy, and previously placed hardware or bone graft material.

Common revision procedures may include:

• Removing scar tissue that is compressing spinal nerves
• Correcting hardware complications such as loose or broken instrumentation
• Extending a prior fusion to additional spinal segments, often prompted by adjacent segment disease
• Completing decompression of nerves that were inadequately addressed in the first operation

Each of these approaches introduces additional risk. Key concerns include:

• Elevated surgical risk: Repeat operations on the same spinal region carry higher rates of infection, nerve injury, dural tears (spinal fluid leakage), and excessive bleeding compared with primary procedures.
• Extended recovery: Recovery from revision spinal fusion can extend well beyond the already lengthy timeline of a first-time fusion—often six months or longer—due to increased tissue trauma and inflammation. Many patients require more intensive pain management and prolonged physical therapy during this period.
• Adjacent segment disease (ASD) progression: Extending a fusion to treat ASD often accelerates stress on the next adjacent level, potentially creating a cycle of further degeneration and additional surgeries.
• Increased scar tissue: Each surgical intervention produces additional scar tissue. Scar tissue can itself become a pain generator by encasing spinal nerves, and it makes any future intervention more technically challenging.
• Uncertain outcomes: Success rates for revision procedures tend to be lower than for primary surgeries, and outcomes vary considerably by patient and indication. A meaningful proportion of revision patients continue to report significant pain or require further intervention within years of the procedure.

For many patients, the cumulative risks of repeat surgery prompt a genuine search for alternative approaches. Learn more about what to consider in our article on 5 signs to get a second opinion before spinal fusion.

Biologic Disc Repair: A Minimally Invasive Alternative

Biologic disc repair—specifically intra-annular fibrin injection—represents a fundamentally different philosophy toward chronic back pain. Rather than removing disc material, fusing vertebrae, or placing hardware, the fibrin procedure focuses on repairing the structural integrity of the damaged disc from within.

The Root Cause: Annular Tears

Many cases of chronic discogenic pain originate from annular tears—small fissures in the tough outer layer (annulus fibrosus) of the intervertebral disc. When the annulus is torn, the gel-like nucleus pulposus can leak outward, irritating surrounding nerves and triggering an inflammatory pain cycle. Traditional surgeries often do not directly address these tears; they may remove the herniated fragment or fuse the segment, but the underlying annular damage may remain or worsen over time.

For a deeper look at how annular tears drive chronic low back pain, see our resource on annular tears as a root cause of back pain.

How Intra-Annular Fibrin Injection Works

The fibrin procedure involves injecting a fibrin sealant—a protein naturally involved in wound healing throughout the body—directly into the damaged disc under fluoroscopic (real-time X-ray) guidance. The fibrin acts as a biological scaffold that:

• Seals annular tears: Closing the fissure prevents continued leakage of inflammatory nucleus material onto adjacent nerves.
• Stabilizes the disc environment: The seal helps reduce micro-motion at the tear site, which may help limit further structural deterioration in some patients.
• Promotes a healing environment: The fibrin scaffold may support the body’s own regenerative processes within the disc, creating conditions for longer-term structural repair.

The procedure is typically performed on an outpatient basis under local anesthesia with light sedation. There are no large incisions, no spinal hardware, and no fusion of vertebrae. Most patients can return to light daily activities within a few days to a week, with a gradual return to fuller activity over the following weeks—a notably shorter disruption than revision surgery recovery timelines.

Addressing the Pain Source, Not Just the Symptoms

Epidural steroid injections are commonly offered to FBSS patients as a pain management measure, but they address inflammation temporarily rather than the structural source of pain. The fibrin procedure, by contrast, targets the underlying disc pathology. The goal is to help the body repair the disc rather than to mask discomfort—an important distinction for patients who have already exhausted temporary measures without lasting benefit.

For a comparison of these approaches, see our article on epidural steroid injections vs. annular tear repair.

Comparing the Two Paths: Key Distinctions

Invasiveness and Recovery

Revision surgery requires incisions, retraction of muscle and tissue, and often the manipulation or addition of spinal hardware. Hospital stays, significant postoperative pain management, and months-long recovery are common. Intra-annular fibrin injection, by contrast, involves only a needle puncture, preserves surrounding tissue, and allows most patients to return to light activity within days. Recovery varies by individual in both cases, but the contrast in procedural burden is substantial.

Preservation of Spinal Mechanics

Spinal fusion permanently eliminates motion at the treated level and redistributes mechanical stress to adjacent segments—a known driver of adjacent segment disease. Biologic disc repair preserves the disc’s natural position and function. The objective is restoration of a healthier disc environment without altering spinal biomechanics. This distinction matters significantly for patients who depend on spinal mobility for work, activity, or quality of life.

Applicability After Prior Surgery

One notable aspect of the fibrin procedure is that it may be appropriate for patients who have already undergone one or more spinal surgeries, provided their persistent pain is primarily discogenic in origin—meaning it stems from ongoing disc pathology such as annular tears rather than from nerve scarring, hardware failure, or instability that would require a structural correction. A careful diagnostic evaluation determines whether this pathway is appropriate for a given patient.

For related patient stories and clinical context, see after failed back surgery: is biologic disc repair your next step? and avoiding revision surgery: biologic disc repair as an alternative.

Who May Be a Candidate for Annular Tear Repair After Failed Surgery?

Candidacy for intra-annular fibrin injection is determined through a thorough evaluation that typically includes a comprehensive medical history review, physical examination, and advanced imaging such as MRI. Our clinical team looks for clear evidence of annular tears as the primary pain generator.

For FBSS patients specifically, the evaluation focuses on whether persistent pain is still driven by disc pathology. Candidates who may benefit include those with:

• Confirmed annular tears on imaging that were not directly addressed by prior surgery
• Continued discogenic pain after discectomy, laminectomy, or incomplete fusion
• Symptoms that have not responded adequately to conservative care, physical therapy, or pain injections
• No current need for urgent structural correction (such as significant instability or progressive neurological deficit)

Not every patient with FBSS is a suitable candidate for biologic disc repair. Candidacy is evaluated individually, and some patients may be better served by revision surgery, additional conservative care, or a combined approach. The diagnostic process is designed to distinguish between these scenarios clearly.

For a self-assessment framework, visit our guide on am I a candidate for biologic disc repair?

Expert Take

Our clinical team has observed that many patients referred for revision surgery still have identifiable annular tears as a significant component of their ongoing pain. In those cases, addressing the disc pathology directly—rather than pursuing another structural operation—may offer a more targeted and less burdensome path to improvement. Each case is evaluated individually, and no single approach is appropriate for all patients.

Making an Informed Decision for Your Spine Health

Choosing between revision surgery and a regenerative approach after failed back surgery is one of the most consequential decisions a spine patient can face. Both paths carry trade-offs, and the right choice depends heavily on the individual’s specific diagnosis, pain source, surgical history, overall health, and personal goals.

We encourage patients to ask their care team detailed questions about:

• What specific structural problem would revision surgery correct, and how confident is the team in that diagnosis?
• Is there evidence of ongoing disc pathology—particularly annular tears—that has not been directly addressed?
• What are the realistic recovery expectations and risk profiles for each option?
• Has a regenerative or biologic approach been formally evaluated as part of the treatment plan?

Seeking a second opinion before committing to revision surgery is a reasonable and often advisable step. Our clinical team is available to provide thorough evaluations and honest assessments of whether biologic disc repair may be appropriate for your situation.

For broader context on non-surgical options and recovery, explore our resources on 5 non-surgical disc treatments for chronic back pain and what to expect during recovery after spine treatment.

Ready to explore whether intra-annular fibrin injection may be appropriate for your situation? Contact Valor Spine to schedule a comprehensive consultation with our clinical team.